BPA for signifor, carbaglu, cystadane, isturisa, and cystadrops

Ended Awarded Last action

Contract number
36E79721A0018
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$3,156,115.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Recordati Rare Diseases Inc. was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs' National Acquisition Center on July 13, 2021, with an ultimate completion date of July 12, 2026. The contract carries a ceiling value of $3.16 million and operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without set-aside designations. This BPA establishes a firm fixed-price procurement vehicle for five specialized orphan pharmaceutical products: Signifor (pasireotide) for treating Cushing's disease and acromegaly, Isturisa (osilodrostat) for managing Cushing's syndrome, Carbaglu (carglumic acid) for hyperammonemia, Cystadane (betaine) for homocystinuria, and Cystadrops (cysteamine) for cystinosis. These medications address uncommon endocrine and metabolic disorders affecting the veteran population and other federal healthcare beneficiaries.

The contract integrates with Recordati's broader Federal Supply Schedule presence and supports the Veterans Integrated Service Networks' capability to access reliable supplies of critical orphan drugs with limited commercial availability. Recordati Rare Diseases Inc., a New Jersey-headquartered subsidiary of the international Recordati Group with manufacturing and distribution operations in Bartlett, Tennessee, functions as the prime contractor with no identified subcontractor involvement. Delivery orders issued under this BPA have been distributed to multiple Veterans Integrated Service Networks, including VISN 5 and VISN 20, which serve regions across Tennessee, Kentucky, the Pacific Northwest, and central New Jersey. The complementary structure of this single-award BPA alongside Recordati's broader multiple-award Federal Supply Schedule contract provides the Department of Veterans Affairs with streamlined procurement flexibility while ensuring continuity of supply for specialized pharmaceutical treatments essential to comprehensive veteran healthcare services.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00016 · 2026 public law pricing updates. $0
Supplemental Agreement for work within scope P00015 · This modification is issued to delete 2 carglumic acid ndcs from BPA 36E79721A0018 $0
Supplemental Agreement for work within scope P00013 · Price increase and 2 isturisa NDC deletions $0
Exercise an Option P00014 · Exercise option year 4 on BPA 36E79721A0018 $0
Supplemental Agreement for work within scope P00012 · 2025 public law pricing update. $0
Other Administrative Action P00011 · This modification is issued to delete 2 ndcs on BPA 36E79721A0018. $0
Exercise an Option P00010 · This modification is issued to exercise option year 3 on BPA 36E79721A0018. $0
Supplemental Agreement for work within scope P00008 · Product deletions $0
Supplemental Agreement for work within scope P00009 · 2024 public law pricing updates $0
Exercise an Option P00007 · Exercise option year 2 - BPA 36E79721A0018 $0
Supplemental Agreement for work within scope P00005 · NDC change and ordering form updates $0
Supplemental Agreement for work within scope P00006 · 2023 public law updates $0
Supplemental Agreement for work within scope P00003 · Incorporate 3 NDC changes on BPA 36E79721A0018 $0
Exercise an Option P00004 · Exercise of option year 1 on BPA 36E79721A0018 $0
Supplemental Agreement for work within scope P00001 · Incorporate 4 NDC changes $0
Supplemental Agreement for work within scope P00002 · 2022 public law pricing updates $0
Original award $0
Show all 17

Quick answers

Who was awarded contract 36E79721A0018?

36E79721A0018 was awarded to Recordati Rare Diseases Inc. by National Acquisition Center (Headquarters) on July 13, 2021.

How much is contract 36E79721A0018 worth?

36E79721A0018's own ceiling is $3,156,115.

Who can order from contract 36E79721A0018?

36E79721A0018 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79721A0018 under another contract?

Yes. 36E79721A0018 is a blanket purchase agreement under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79721A0018 competed?

The extent of competition for 36E79721A0018 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV